6.
da Silva Motta Junior J, Dos Santos Miggiolaro A, Nagashima S, De Paula C, Baena C, Scharfstein J
. Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis. Front Immunol. 2020; 11:574862.
PMC: 7530169.
DOI: 10.3389/fimmu.2020.574862.
View
7.
Baratella E, Bussani R, Zanconati F, Marrocchio C, Fabiola G, Braga L
. Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways?. ERJ Open Res. 2021; 7(3).
PMC: 8381265.
DOI: 10.1183/23120541.00346-2021.
View
8.
Tchougounova E, Lundequist A, Fajardo I, Winberg J, Abrink M, Pejler G
. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem. 2004; 280(10):9291-6.
DOI: 10.1074/jbc.M410396200.
View
9.
Jimenez M, Cervantes-Garcia D, Cordova-Davalos L, Perez-Rodriguez M, Gonzalez-Espinosa C, Salinas E
. Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles. Front Immunol. 2021; 12:685865.
PMC: 8240065.
DOI: 10.3389/fimmu.2021.685865.
View
10.
Iwashita H, Kawabata Y, Hayashi H, Matsushita S, Yamashiro T, Matsumura M
. Frequency of subclinical interstitial lung disease in COVID-19 autopsy cases: potential risk factors of severe pneumonia. BMC Pulm Med. 2023; 23(1):408.
PMC: 10612296.
DOI: 10.1186/s12890-023-02692-1.
View
11.
Bhardwaj A, Sapra L, Saini C, Azam Z, Mishra P, Verma B
. COVID-19: Immunology, Immunopathogenesis and Potential Therapies. Int Rev Immunol. 2021; 41(2):171-206.
PMC: 7919479.
DOI: 10.1080/08830185.2021.1883600.
View
12.
Li X, Zhuang J, Rayford H, Zhang H, Shu R, Uhal B
. Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA. Curr Pharm Des. 2007; 13(12):1257-68.
DOI: 10.2174/138161207780618867.
View
13.
Li L, Li Y, Reddel S, Cherrian M, Friend D, Stevens R
. Identification of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy, and drug-reactive patients. J Immunol. 1998; 161(9):5079-86.
View
14.
Goldstein S, Leong J, Bunnett N
. Human mast cell proteases hydrolyze neurotensin, kinetensin and Leu5-enkephalin. Peptides. 1991; 12(5):995-1000.
DOI: 10.1016/0196-9781(91)90049-u.
View
15.
Hellman L, Akula S, Fu Z, Wernersson S
. Mast Cell and Basophil Granule Proteases - Targets and Function. Front Immunol. 2022; 13:918305.
PMC: 9294451.
DOI: 10.3389/fimmu.2022.918305.
View
16.
Lundequist A, Tchougounova E, Abrink M, Pejler G
. Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II. J Biol Chem. 2004; 279(31):32339-44.
DOI: 10.1074/jbc.M405576200.
View
17.
Ahmad Alhiyari M, Ata F, Islam Alghizzawi M, Bilal A, Salih Abdulhadi A, Yousaf Z
. Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection. IDCases. 2021; 23:e01041.
PMC: 7785952.
DOI: 10.1016/j.idcr.2020.e01041.
View
18.
Wygrecka M, Kwapiszewska G, Jablonska E, von Gerlach S, Henneke I, Zakrzewicz D
. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011; 183(12):1703-14.
DOI: 10.1164/rccm.201009-1479OC.
View
19.
Zhou Y, Pan P, Yao L, Su M, He P, Niu N
. CD117-positive cells of the heart: progenitor cells or mast cells?. J Histochem Cytochem. 2009; 58(4):309-16.
PMC: 2842594.
DOI: 10.1369/jhc.2009.955146.
View
20.
Ross B, DOrleans-Juste P, Giaid A
. Potential role of endothelin-1 in pulmonary fibrosis: from the bench to the clinic. Am J Respir Cell Mol Biol. 2009; 42(1):16-20.
DOI: 10.1165/rcmb.2009-0175TR.
View